Burning Rock Biotech Limited (BNR) Inventory Turnover Ratio, from fourth quarter 2025 to fourth quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Burning Rock Biotech Limited  (NASDAQ: BNR)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Burning Rock Biotech Limited Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Burning Rock Biotech Limited's inventory turnover ratio, the ratio that measures Burning Rock Biotech Limited's ability to manage its supply chain, sequentially decreased to 3.39 in the fourth quarter 2025, which does not come as a surprise, as the Burning Rock Biotech Limited continue to experience headwinds, which also impact its supply chain. Burning Rock Biotech Limited's average inventory processing period in the Dec 31 2025 quarter, has increased to 108 days, from 99 days, in the 0 quarter.

Within Healthcare sector 50 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2025, to 1301, from total ranking in the third quarter 2025 at 1414.

BNR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Burning Rock Biotech Limited Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BNR Inventory Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Inventory Growth 14.83 % -19.04 % -19.04 % -19.04 % -33.85 %
Y / Y Cost of Sales Growth -7.03 % - - - -14.33 %
Inventory Turnover Ratio (TTM) 3.39 - - - 3.04
BNR's Total Ranking # 1301 # 1414 # # #
Average inventory processing period 108 - - - 120
Seq. Inventory Growth -67.56 % 0 % 0 % 254.03 % -77.13 %
Seq. Cost of Sales Growth - - - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 5
Healthcare Sector # 51
Overall Market # 1301

Inventory Turnover Ratio Statistics
High Average Low
10.71 7.41 4.19
(Dec 31 2024)   (Dec 31 2021)



BNR Company Profile >> Back to BNR Efficiency Comparisons >> Compare BNR Inventory Turnover Ratio to its Competitors

Financial Statements
Burning Rock Biotech Limited's Inventories $ 2 Millions Visit BNR's Balance sheet
Burning Rock Biotech Limited's Cost of Revenues TTM $ 20 Millions Visit BNR's Income Statement
What are BNR's Sales? Visit BNR's Sales by Segment

Other Inventory Turnover Ratios
Burning Rock Biotech Limited's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BNR's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BNR's Competitors
Inventory Turnover Ratio for BNR's Suppliers
Inventory Turnover Ratio for BNR's Customers

You may also want to know
BNR's Sales Growth Rates BNR's Pe Price to earnings ratio BNR's Receivables Turnover Ratio BNR's Stock Quote
BNR's Net Income Growth Rates BNR's Ps Price to Sales ratio BNR's Sales per Employee BNR's Asset Turnover Ratio
BNR's Net Margin BNR's Pb Price to Book ratio BNR's Financial Strength Ratios BNR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2025 Inventories at quarter ending Dec 31 2025
Harvard Apparatus Regenerative Technology Inc   22.87 $ 0.646  Millions$ 0  Millions
Sbc Medical Group Holdings Incorporated  22.84 $ 44.941  Millions$ 2  Millions
Lucid Diagnostics Inc   21.41 $ 9.784  Millions$ 0  Millions
Rosecliff Acquisition Corp I  21.00 $ 11.442  Millions$ 1  Millions
Teladoc Health Inc   20.01 $ 771.593  Millions$ 39  Millions
Agape Atp Corporation  19.56 $ 0.686  Millions$ 0  Millions
Labcorp Holdings Inc   19.37 $ 9,939.200  Millions$ 513  Millions
Aspira Women s Health inc   19.20 $ 5.142  Millions$ 0  Millions
Adapthealth Corp   18.22 $ 2,635.658  Millions$ 145  Millions
Hutchmed china Limited  18.01 $ 336.349  Millions$ 19  Millions
Neuronetics Inc   17.21 $ 76.000  Millions$ 4  Millions
Aurinia Pharmaceuticals Inc   16.31 $ 32.665  Millions$ 2  Millions
Nano X Imaging Ltd  14.93 $ 25.809  Millions$ 2  Millions
Precipio inc   14.80 $ 13.343  Millions$ 1  Millions
Rockwell Medical inc   13.74 $ 57.000  Millions$ 4  Millions
Natera Inc   13.62 $ 809.395  Millions$ 59  Millions
The Oncology Institute Inc   12.87 $ 205.502  Millions$ 16  Millions
Casi Pharmaceuticals inc   12.66 $ 10.636  Millions$ 1  Millions
Cryo cell International Inc   11.94 $ 7.377  Millions$ 1  Millions
Irhythm Holdings Inc   11.85 $ 219.000  Millions$ 18  Millions
Edap Tms Sa  11.73 $ 95.511  Millions$ 8  Millions
Infusystem Holdings Inc  11.10 $ 63.140  Millions$ 6  Millions
Option Care Health Inc   10.99 $ 4,561.000  Millions$ 415  Millions
Genedx Holdings Corp   10.51 $ 129.000  Millions$ 12  Millions
Star Equity Holdings Inc   10.28 $ 87.159  Millions$ 8  Millions
Earth Science Tech Inc   9.97 $ 7.141  Millions$ 1  Millions
Zevra Therapeutics Inc   9.73 $ 16.482  Millions$ 2  Millions
Nutriband Inc   9.68 $ 1.470  Millions$ 0  Millions
Concord Medical Services Holdings Ltd  9.35 $ 62.160  Millions$ 7  Millions
Lantheus Holdings Inc   9.29 $ 599.000  Millions$ 64  Millions

Date modified: 2026-09-08T15:11:40+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.